Global Allergy Medicine research
Global Allergy Medicine research

Allergy Medicine Comprehensive Study by Type (Tablet, Liquid), Allergy (Drug Allergy, Food Allergy, Skin Allergy, Insect Allergy, Latex Allergy, Others), Symptoms (Hives, Fever) Players and Region - Global Market Outlook to 2026

Allergy Medicine Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Oct 2021 Edition 214 Pages 221 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Allergy involves an exaggerated response of the immune system, often to common substances such as foods, furry animal dander, or pollen. Substances that cause allergic reactions are allergens. This reaction could cause coughing, sneezing, hives, rashes, itchy eyes, a runny nose, and a scratchy throat.This growth is primarily driven by Factors such as increased risk of developing a drug allergy include age, gender, genetic polymorphisms, certain viral infections, and drug-related factors are expected to drive the market, Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments is fuelling the growth of the market, Increasing prevalence of allergens and Increased investment by the manufacturers on the development of novel allergic treatments and rising importance for self-medication.

Globally, a noticeable market trend is evident Increase in the number of people suffering from food allergies among both children and adults. Major Players, such as Sanofi (France), Johnson and Johnson (US), Bayer (Germany), Matrixx Initiatives (US), AstraZeneca (UK), GSK (UK), Pfizer (US) and Chattem (US) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

April 28, 2021: Pfizer acquired Amplyx Pharmaceuticals, Inc. This acquisition developed the therapies for debilitating and life-threatening diseases that affect people with their immune systems.

Market Drivers
  • Factors such as increased risk of developing a drug allergy include age, gender, genetic polymorphisms, certain viral infections, and drug-related factors are expected to drive the market
  • Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments is fuelling the growth of the market
  • Increasing prevalence of allergens
  • Increased investment by the manufacturers on the development of novel allergic treatments and rising importance for self-medication

Market Trend
  • Increase in the number of people suffering from food allergies among both children and adults

Restraints
  • Lack of awareness about allergies is expected to restraint the market

Opportunities
The rise in awareness among patients regarding food allergies and drug allergies is projected to grow of the market during the forecast period and Rising cases of allergies and an increase in the demand for allergy immunotherapy are expected to growth of the market over the forecast period
Challenges
Exposure to allergens that identified as an influential environmental factor, whereas passive smoking and pollution may act as an adjuvant

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Allergy Medicine Study Sheds Light on
— The Allergy Medicine Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Allergy Medicine industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Allergy Medicine industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Frequently Asked Questions (FAQ):

1. What are the years considered in the Allergy Medicine Market?
Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026

2. Who are the key players profiled in the Allergy Medicine Market?
Companies that are profiled in Global Allergy Medicine Market are Sanofi (France), Johnson and Johnson (US), Bayer (Germany), Matrixx Initiatives (US), AstraZeneca (UK), GSK (UK), Pfizer (US) and Chattem (US) etc.

3. What is Allergy Medicine Market?
Allergy involves an exaggerated response of the immune system, often to common substances such as foods, furry animal dander, or pollen. Substances that cause allergic reactions are allergens. This reaction could cause coughing, sneezing, hives, rashes, itchy eyes, a runny nose, and a scratchy throat.
Report Objectives / Segmentation Covered
By Type
  • Tablet
  • Liquid
By Allergy
  • Drug Allergy
  • Food Allergy
  • Skin Allergy
  • Insect Allergy
  • Latex Allergy
  • Others

By Symptoms
  • Hives
  • Fever

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Factors such as increased risk of developing a drug allergy include age, gender, genetic polymorphisms, certain viral infections, and drug-related factors are expected to drive the market
      • 3.2.2. Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments is fuelling the growth of the market
      • 3.2.3. Increasing prevalence of allergens
      • 3.2.4. Increased investment by the manufacturers on the development of novel allergic treatments and rising importance for self-medication
    • 3.3. Market Challenges
      • 3.3.1. Exposure to allergens that identified as an influential environmental factor, whereas passive smoking and pollution may act as an adjuvant
    • 3.4. Market Trends
      • 3.4.1. Increase in the number of people suffering from food allergies among both children and adults
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Allergy Medicine, by Type, Allergy, Symptoms and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Allergy Medicine (Value)
      • 5.2.1. Global Allergy Medicine by: Type (Value)
        • 5.2.1.1. Tablet
        • 5.2.1.2. Liquid
      • 5.2.2. Global Allergy Medicine by: Allergy (Value)
        • 5.2.2.1. Drug Allergy
        • 5.2.2.2. Food Allergy
        • 5.2.2.3. Skin Allergy
        • 5.2.2.4. Insect Allergy
        • 5.2.2.5. Latex Allergy
        • 5.2.2.6. Others
      • 5.2.3. Global Allergy Medicine Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Allergy Medicine (Price)
      • 5.3.1. Global Allergy Medicine by: Type (Price)
  • 6. Allergy Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanofi (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson and Johnson (US)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Matrixx Initiatives (US)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca (UK)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GSK (UK)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer (US)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Chattem (US)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Allergy Medicine Sale, by Type, Allergy, Symptoms and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Allergy Medicine (Value)
      • 7.2.1. Global Allergy Medicine by: Type (Value)
        • 7.2.1.1. Tablet
        • 7.2.1.2. Liquid
      • 7.2.2. Global Allergy Medicine by: Allergy (Value)
        • 7.2.2.1. Drug Allergy
        • 7.2.2.2. Food Allergy
        • 7.2.2.3. Skin Allergy
        • 7.2.2.4. Insect Allergy
        • 7.2.2.5. Latex Allergy
        • 7.2.2.6. Others
      • 7.2.3. Global Allergy Medicine Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Allergy Medicine (Price)
      • 7.3.1. Global Allergy Medicine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Allergy Medicine: by Type(USD Million)
  • Table 2. Allergy Medicine Tablet , by Region USD Million (2015-2020)
  • Table 3. Allergy Medicine Liquid , by Region USD Million (2015-2020)
  • Table 4. Allergy Medicine: by Allergy(USD Million)
  • Table 5. Allergy Medicine Drug Allergy , by Region USD Million (2015-2020)
  • Table 6. Allergy Medicine Food Allergy , by Region USD Million (2015-2020)
  • Table 7. Allergy Medicine Skin Allergy , by Region USD Million (2015-2020)
  • Table 8. Allergy Medicine Insect Allergy , by Region USD Million (2015-2020)
  • Table 9. Allergy Medicine Latex Allergy , by Region USD Million (2015-2020)
  • Table 10. Allergy Medicine Others , by Region USD Million (2015-2020)
  • Table 11. South America Allergy Medicine, by Country USD Million (2015-2020)
  • Table 12. South America Allergy Medicine, by Type USD Million (2015-2020)
  • Table 13. South America Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 14. South America Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 15. Brazil Allergy Medicine, by Type USD Million (2015-2020)
  • Table 16. Brazil Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 17. Brazil Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 18. Argentina Allergy Medicine, by Type USD Million (2015-2020)
  • Table 19. Argentina Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 20. Argentina Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 21. Rest of South America Allergy Medicine, by Type USD Million (2015-2020)
  • Table 22. Rest of South America Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 23. Rest of South America Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 24. Asia Pacific Allergy Medicine, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Allergy Medicine, by Type USD Million (2015-2020)
  • Table 26. Asia Pacific Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 27. Asia Pacific Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 28. China Allergy Medicine, by Type USD Million (2015-2020)
  • Table 29. China Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 30. China Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 31. Japan Allergy Medicine, by Type USD Million (2015-2020)
  • Table 32. Japan Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 33. Japan Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 34. India Allergy Medicine, by Type USD Million (2015-2020)
  • Table 35. India Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 36. India Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 37. South Korea Allergy Medicine, by Type USD Million (2015-2020)
  • Table 38. South Korea Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 39. South Korea Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 40. Taiwan Allergy Medicine, by Type USD Million (2015-2020)
  • Table 41. Taiwan Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 42. Taiwan Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 43. Australia Allergy Medicine, by Type USD Million (2015-2020)
  • Table 44. Australia Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 45. Australia Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 46. Rest of Asia-Pacific Allergy Medicine, by Type USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 49. Europe Allergy Medicine, by Country USD Million (2015-2020)
  • Table 50. Europe Allergy Medicine, by Type USD Million (2015-2020)
  • Table 51. Europe Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 52. Europe Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 53. Germany Allergy Medicine, by Type USD Million (2015-2020)
  • Table 54. Germany Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 55. Germany Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 56. France Allergy Medicine, by Type USD Million (2015-2020)
  • Table 57. France Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 58. France Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 59. Italy Allergy Medicine, by Type USD Million (2015-2020)
  • Table 60. Italy Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 61. Italy Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 62. United Kingdom Allergy Medicine, by Type USD Million (2015-2020)
  • Table 63. United Kingdom Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 64. United Kingdom Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 65. Netherlands Allergy Medicine, by Type USD Million (2015-2020)
  • Table 66. Netherlands Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 67. Netherlands Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 68. Rest of Europe Allergy Medicine, by Type USD Million (2015-2020)
  • Table 69. Rest of Europe Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 70. Rest of Europe Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 71. MEA Allergy Medicine, by Country USD Million (2015-2020)
  • Table 72. MEA Allergy Medicine, by Type USD Million (2015-2020)
  • Table 73. MEA Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 74. MEA Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 75. Middle East Allergy Medicine, by Type USD Million (2015-2020)
  • Table 76. Middle East Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 77. Middle East Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 78. Africa Allergy Medicine, by Type USD Million (2015-2020)
  • Table 79. Africa Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 80. Africa Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 81. North America Allergy Medicine, by Country USD Million (2015-2020)
  • Table 82. North America Allergy Medicine, by Type USD Million (2015-2020)
  • Table 83. North America Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 84. North America Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 85. United States Allergy Medicine, by Type USD Million (2015-2020)
  • Table 86. United States Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 87. United States Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 88. Canada Allergy Medicine, by Type USD Million (2015-2020)
  • Table 89. Canada Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 90. Canada Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 91. Mexico Allergy Medicine, by Type USD Million (2015-2020)
  • Table 92. Mexico Allergy Medicine, by Allergy USD Million (2015-2020)
  • Table 93. Mexico Allergy Medicine, by Symptoms USD Million (2015-2020)
  • Table 94. Allergy Medicine: by Type(USD/Units)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Allergy Medicine: by Type(USD Million)
  • Table 104. Allergy Medicine Tablet , by Region USD Million (2021-2026)
  • Table 105. Allergy Medicine Liquid , by Region USD Million (2021-2026)
  • Table 106. Allergy Medicine: by Allergy(USD Million)
  • Table 107. Allergy Medicine Drug Allergy , by Region USD Million (2021-2026)
  • Table 108. Allergy Medicine Food Allergy , by Region USD Million (2021-2026)
  • Table 109. Allergy Medicine Skin Allergy , by Region USD Million (2021-2026)
  • Table 110. Allergy Medicine Insect Allergy , by Region USD Million (2021-2026)
  • Table 111. Allergy Medicine Latex Allergy , by Region USD Million (2021-2026)
  • Table 112. Allergy Medicine Others , by Region USD Million (2021-2026)
  • Table 113. South America Allergy Medicine, by Country USD Million (2021-2026)
  • Table 114. South America Allergy Medicine, by Type USD Million (2021-2026)
  • Table 115. South America Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 116. South America Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 117. Brazil Allergy Medicine, by Type USD Million (2021-2026)
  • Table 118. Brazil Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 119. Brazil Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 120. Argentina Allergy Medicine, by Type USD Million (2021-2026)
  • Table 121. Argentina Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 122. Argentina Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 123. Rest of South America Allergy Medicine, by Type USD Million (2021-2026)
  • Table 124. Rest of South America Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 125. Rest of South America Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 126. Asia Pacific Allergy Medicine, by Country USD Million (2021-2026)
  • Table 127. Asia Pacific Allergy Medicine, by Type USD Million (2021-2026)
  • Table 128. Asia Pacific Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 129. Asia Pacific Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 130. China Allergy Medicine, by Type USD Million (2021-2026)
  • Table 131. China Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 132. China Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 133. Japan Allergy Medicine, by Type USD Million (2021-2026)
  • Table 134. Japan Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 135. Japan Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 136. India Allergy Medicine, by Type USD Million (2021-2026)
  • Table 137. India Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 138. India Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 139. South Korea Allergy Medicine, by Type USD Million (2021-2026)
  • Table 140. South Korea Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 141. South Korea Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 142. Taiwan Allergy Medicine, by Type USD Million (2021-2026)
  • Table 143. Taiwan Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 144. Taiwan Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 145. Australia Allergy Medicine, by Type USD Million (2021-2026)
  • Table 146. Australia Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 147. Australia Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 148. Rest of Asia-Pacific Allergy Medicine, by Type USD Million (2021-2026)
  • Table 149. Rest of Asia-Pacific Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 150. Rest of Asia-Pacific Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 151. Europe Allergy Medicine, by Country USD Million (2021-2026)
  • Table 152. Europe Allergy Medicine, by Type USD Million (2021-2026)
  • Table 153. Europe Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 154. Europe Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 155. Germany Allergy Medicine, by Type USD Million (2021-2026)
  • Table 156. Germany Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 157. Germany Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 158. France Allergy Medicine, by Type USD Million (2021-2026)
  • Table 159. France Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 160. France Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 161. Italy Allergy Medicine, by Type USD Million (2021-2026)
  • Table 162. Italy Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 163. Italy Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 164. United Kingdom Allergy Medicine, by Type USD Million (2021-2026)
  • Table 165. United Kingdom Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 166. United Kingdom Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 167. Netherlands Allergy Medicine, by Type USD Million (2021-2026)
  • Table 168. Netherlands Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 169. Netherlands Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 170. Rest of Europe Allergy Medicine, by Type USD Million (2021-2026)
  • Table 171. Rest of Europe Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 172. Rest of Europe Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 173. MEA Allergy Medicine, by Country USD Million (2021-2026)
  • Table 174. MEA Allergy Medicine, by Type USD Million (2021-2026)
  • Table 175. MEA Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 176. MEA Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 177. Middle East Allergy Medicine, by Type USD Million (2021-2026)
  • Table 178. Middle East Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 179. Middle East Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 180. Africa Allergy Medicine, by Type USD Million (2021-2026)
  • Table 181. Africa Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 182. Africa Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 183. North America Allergy Medicine, by Country USD Million (2021-2026)
  • Table 184. North America Allergy Medicine, by Type USD Million (2021-2026)
  • Table 185. North America Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 186. North America Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 187. United States Allergy Medicine, by Type USD Million (2021-2026)
  • Table 188. United States Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 189. United States Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 190. Canada Allergy Medicine, by Type USD Million (2021-2026)
  • Table 191. Canada Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 192. Canada Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 193. Mexico Allergy Medicine, by Type USD Million (2021-2026)
  • Table 194. Mexico Allergy Medicine, by Allergy USD Million (2021-2026)
  • Table 195. Mexico Allergy Medicine, by Symptoms USD Million (2021-2026)
  • Table 196. Allergy Medicine: by Type(USD/Units)
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Allergy Medicine: by Type USD Million (2015-2020)
  • Figure 5. Global Allergy Medicine: by Allergy USD Million (2015-2020)
  • Figure 6. South America Allergy Medicine Share (%), by Country
  • Figure 7. Asia Pacific Allergy Medicine Share (%), by Country
  • Figure 8. Europe Allergy Medicine Share (%), by Country
  • Figure 9. MEA Allergy Medicine Share (%), by Country
  • Figure 10. North America Allergy Medicine Share (%), by Country
  • Figure 11. Global Allergy Medicine: by Type USD/Units (2015-2020)
  • Figure 12. Global Allergy Medicine share by Players 2020 (%)
  • Figure 13. Global Allergy Medicine share by Players (Top 3) 2020(%)
  • Figure 14. Global Allergy Medicine share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 17. Sanofi (France) Revenue: by Geography 2020
  • Figure 18. Johnson and Johnson (US) Revenue, Net Income and Gross profit
  • Figure 19. Johnson and Johnson (US) Revenue: by Geography 2020
  • Figure 20. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Bayer (Germany) Revenue: by Geography 2020
  • Figure 22. Matrixx Initiatives (US) Revenue, Net Income and Gross profit
  • Figure 23. Matrixx Initiatives (US) Revenue: by Geography 2020
  • Figure 24. AstraZeneca (UK) Revenue, Net Income and Gross profit
  • Figure 25. AstraZeneca (UK) Revenue: by Geography 2020
  • Figure 26. GSK (UK) Revenue, Net Income and Gross profit
  • Figure 27. GSK (UK) Revenue: by Geography 2020
  • Figure 28. Pfizer (US) Revenue, Net Income and Gross profit
  • Figure 29. Pfizer (US) Revenue: by Geography 2020
  • Figure 30. Chattem (US) Revenue, Net Income and Gross profit
  • Figure 31. Chattem (US) Revenue: by Geography 2020
  • Figure 32. Global Allergy Medicine: by Type USD Million (2021-2026)
  • Figure 33. Global Allergy Medicine: by Allergy USD Million (2021-2026)
  • Figure 34. South America Allergy Medicine Share (%), by Country
  • Figure 35. Asia Pacific Allergy Medicine Share (%), by Country
  • Figure 36. Europe Allergy Medicine Share (%), by Country
  • Figure 37. MEA Allergy Medicine Share (%), by Country
  • Figure 38. North America Allergy Medicine Share (%), by Country
  • Figure 39. Global Allergy Medicine: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Sanofi (France)
  • Johnson and Johnson (US)
  • Bayer (Germany)
  • Matrixx Initiatives (US)
  • AstraZeneca (UK)
  • GSK (UK)
  • Pfizer (US)
  • Chattem (US)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation